CVE-2010-0615

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in assess.php in evalSMSI 2.1.03 allows remote attackers to inject arbitrary web script or HTML via the reports comment box in a continue_assess action. NOTE: some of these details are obtained from third party information.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.52%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.osvdb.org/62178 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/56154 vdb entry
http://secunia.com/advisories/38478 third party advisory vendor advisory
http://www.securityfocus.com/bid/38116 vdb entry exploit
http://packetstormsecurity.org/1002-exploits/corelan-10-008-evalmsi.txt exploit
http://www.corelan.be:8800/index.php/forum/security-advisories/corelan-10-008-evalmsi-2-1-03-multiple-vulnerabilities/
http://www.securityfocus.com/archive/1/509370/100/0/threaded mailing list

Frequently Asked Questions

What is the severity of CVE-2010-0615?
CVE-2010-0615 has been scored as a medium severity vulnerability.
How to fix CVE-2010-0615?
To fix CVE-2010-0615, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-0615 being actively exploited in the wild?
It is possible that CVE-2010-0615 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.